Keywords: Watson Pharma, Fourth-quarter and full-year 2011 financial results

Watson 4th-quarter beats expectations, with 93% rise in net income

Article | 15 February 2012

US generic drugmaker Watson Pharmaceuticals (NYSE: WPI) reported a whopping 62% increase to $1.5 billion in net revenue for the fourth quarter ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in

Related Companies

Watson Pharmaceuticals

Go to company listing